“…Sichel et al (2004) agreed with the lack of a significant peri-lesional fibrosis [18]. The percentage of success is 50-92% (remaining high even with repeated injections), with 43% of complete and 29,3% of partial remissions [19], whereas the frequency of the recurrences is around 11% [15] and the complications are rare and mostly local (pain, heat, induration, erythema, oedema, swelling, aesthetic sequelae, swallowing difficulty and odynophagia, infections) with sporadic fever, sepsis and shock, especially in patients with allergy for G penicillin [1]. Yoo et al (2009) stressed the safety of OK-432, reporting minor complications only and stating a high long-term efficacy [20].…”